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The event-related potential (ERP) technique has been shown to be useful for evaluating
changes in brain electrical activity associated with different cognitive processes,
particularly in Alzheimer’s disease (AD). Longitudinal studies have shown that a high
proportion of people with amnestic mild cognitive impairment (aMCI) go on to develop
AD. aMCI is divided into two subtypes according to the presence of memory impairment
only (single-domain aMCI: sdaMCI) or impairment of memory and other cognitive
domains (multi-domain aMCI: mdaMCI). The main aim of this study was to examine
the effects of sdaMCI and mdaMCI on the P3a ERP component associated with the
involuntary orientation of attention toward unattended infrequent novel auditory stimuli.
Participants performed an auditory-visual distraction-attention task, in which they were
asked to ignore the auditory stimuli (standard, deviant, and novel) and to attend to the
visual stimuli (responding to some of them: Go stimuli). P3a was identified in the Novel
minus Standard difference waveforms, and reaction times (RTs) and hits (in response to
Go stimuli) were also analyzed. Participants were classified into three groups: Control,
20 adults (mean age (M): 65.8 years); sdaMCI, 19 adults (M: 67 years); and mdaMCI, 11
adults (M: 71 years). In all groups, the RTs were significantly longer when Go stimuli were
preceded by novel (relative to standard) auditory stimuli, suggesting a distraction effect
triggered by novel stimuli; mdaMCI participants made significantly fewer hits than control
and sdaMCI participants. P3a comprised two consecutive phases in all groups: early-
P3a (e-P3a), which may reflect the orienting response toward the irrelevant stimuli, and
late-P3a (l-P3a), which may be a correlate of subsequent evaluation of these stimuli.
The e-P3a amplitude was significantly larger in mdaMCI than in sdaMCI participants,
and the l-P3a amplitude was significantly larger in mdaMCI than in sdaMCI and
Control participants, indicating greater involuntary capture of attention to unattended
novel auditory stimuli and allocation of more attentional resources for the subsequent
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evaluation of these stimuli in mdaMCI participants. The e-P3a and l-P3a components
showed moderate to high sensitivity and specificity for distinguishing between groups,
suggesting that both may represent optimal neurocognitive markers for differentiating
aMCI subtypes.
Keywords: amnestic mild cognitive impairment (aMCI), Alzheimer’s disease (AD), biomarkers, event-related
potentials (ERPs), P3a, involuntary attention
INTRODUCTION
Epidemiological and sociodemographic evidence indicates an
increasing prevalence of Alzheimer’s disease (AD) associated
with the continuous relative increase in the aging population
worldwide (Fratiglioni et al., 2000; Bickel, 2001; Juckel et al., 2008;
Rocca et al., 2012). AD has a profound effect on the quality of
life of the sufferers, their families and carers, as well as a strong
economic impact (Vellone et al., 2008; Sosa-Ortiz et al., 2012;
Wimo et al., 2013). Accurate and early diagnosis of AD is a major
public health concern, as although AD cannot yet be halted or
reversed, recent dementia-specific pharmacological advances can
slow progression of the disease (Vecchio and Määttä, 2011).
People diagnosed with amnestic mild cognitive impairment
(aMCI) display symptoms that indicate possible progression
to AD but that do not interfere with daily living (Petersen,
2004; Fisk, 2005; Petersen et al., 2014). Such people frequently
show signs of memory impairment only (single-domain aMCI:
sdaMCI) or impairment of memory and other cognitive domains
(multi-domain aMCI: mdaMCI). It has been suggested that both
subtypes represent part of a continuous spectrum of MCI, with
mdaMCI being the most severe form of aMCI in terms of
prognosis (Fischer et al., 2007; Petersen and Negash, 2008).
The identification of biomarkers of aMCI could help clinicians
make objective diagnoses, thus enabling the early application
of therapies with the aim of slowing down progression
to AD and also providing opportunities for preventing
the disease via population screening (Henry et al., 2013).
Identification of biomarkers of aMCI usually requires the
application of invasive (e.g., analysis of cerebrospinal fluid)
and/or expensive methods [e.g., positron emission tomography
(PET) or functional magnetic resonance image (fMRI)] (Small
et al., 2006; Hämäläinen et al., 2007; Perneczky et al., 2011).
However, the event-related potential (ERP) technique is non-
invasive, simple and inexpensive (Rossini et al., 2006), making
it an ideal candidate method for identifying biomarkers (Thies
et al., 1999; Jackson and Snyder, 2008).
The ERP technique is well suited to detecting and quantifying
changes in brain electrical activity associated with cognitive
deficits (Katada et al., 2004). In fact, some ERP components have
been found to be altered at early stages of AD (Golob et al., 2009;
Quiroz et al., 2011) and in MCI (see Vecchio and Määttä, 2011;
Bidelman et al., 2017). In addition, changes in ERP components
have been shown to be potentially useful as biomarkers of the
progress of cognitive impairment and subsequent conversion to
dementia in individuals with MCI (for a review, see Cecchi et al.,
2015).
Some ERP studies have used the novelty oddball paradigm
with the aim of evaluating the brain electrical activity related to
orienting response. In this paradigm, three types of stimuli are
presented: standard, target, and novel. The P3b ERP component,
which reflects attentional and memory processes, is elicited in
response to target stimuli. In turn, unexpected stimuli (novel
or deviant) elicit a frontocentral component, namely P3a (or
novelty-P3; Courchesne et al., 1975; Squires et al., 1975; Escera
et al., 2000), considered a psychophysiological index of the
orienting response (Squires et al., 1975; Cycowicz and Friedman,
1997; Friedman et al., 2001). P3a has a shorter peak latency and
a more frontal topographical distribution than P3b and is also
evoked in different conditions (Squires et al., 1975; Escera et al.,
2000).
The P3a component is identified at approximately 300 ms
from deviation onset (Friedman et al., 2001; Horváth et al., 2009).
Generation of P3a seems to involve a broad network of cortical
regions, including the prefrontal cortex, cingulate gyrus, and
hippocampus (Knight et al., 1989; Baudena et al., 1995; Halgren
et al., 1995; Alho et al., 1998). Different studies suggest that P3a
may represent evidence for “transient activation in the neural
network involved in a variety of cognitive tasks that demand
continual updating of task-set information for selection of goal-
directed actions” (Barcelo et al., 2006; Escera and Corral, 2007; as
cited in Correa-Jaraba et al., 2016). It has also been proposed that
rather than reflecting the switch itself, the P3a component may
also indicate the initial unhitching of the focus of attention from
the current information with the aim of preparing for switching
attention (Berti, 2008; as cited in Correa-Jaraba et al., 2016).
It has also been proposed that P3a is elicited in two phases in
response to deviant (Yago et al., 2001; Correa-Jaraba et al., 2016)
and novel sounds in young participants (Escera et al., 1998, 2001;
Correa-Jaraba et al., 2016) and in middle-aged and old adults
(Correa-Jaraba et al., 2016). Mager et al. (2005) observed an early
P3a phase and a consecutive P3a phase (about of 330 ms) in
response to novel auditory stimuli, in young and middle-aged
adults; nevertheless, the latter phase could not be identified in
all participants and was not evaluated (as cited in Correa-Jaraba
et al., 2016). In young, middle-aged and old adults, Correa-Jaraba
et al. (2016) distinguished an early phase, denominated early-
P3a (e-P3a), and a later phase, named late-P3a (l-P3a), which
were considered indexes of the orienting of attention toward -
and evaluation of - the infrequent unexpected (novel or deviant)
stimuli, respectively (for a review see Correa-Jaraba et al., 2016).
The P3a component is affected in several psychiatric and
neurological disorders (Kaipio et al., 1999, 2000; Polo et al.,
2003; Lepistö et al., 2004; Gumenyuk, 2005); however, the
findings of the few studies concerning P3a in AD have been
to some extent inconsistent. Thus, some authors observed a
longer P3a latency in AD patients than in healthy controls,
suggesting delayed orientation to the deviant stimuli in the
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former (Frodl et al., 2002; Juckel et al., 2008). On the other hand,
other authors observed that the P3a amplitude was smaller in
people with mild AD than in healthy controls (Cecchi et al.,
2015), a finding that is in accordance with the decline in attention
and executive function observed in people with mild AD during
neuropsychological testing (Baudic et al., 2006; Cecchi et al.,
2015). However, yet other authors did not observe any difference
in the P3a component parameters between AD patients and
controls (Yamaguchi et al., 2000).
If AD patients show changes in P3a parameters relative to
controls, it is possible that similar changes can be observed in
people with aMCI. However, we are not aware of the existence
of published studies evaluating P3a parameters in people with
aMCI.
The current study was hence designed to evaluate the effects of
aMCI on the P3a component, recorded in response to irrelevant
novel auditory stimuli. The specific aims were as follows: (1)
to identify and characterize the two phases of P3a (e-P3a and
l-P3a) in sdaMCI, mdaMCI and Control groups, (2) to evaluate
differences between Control, sdaMCI and mdaMCI adults in
the e-P3a and l-P3a parameters considered (amplitudes and
latencies), and (3) to determine whether changes in these ERP
parameters are sensitive and specific biomarkers of sdaMCI and
mdaMCI.
An auditory-visual distraction-attention task in which the
participants had to ignore the auditory stimuli (standard, deviant,
and novel) and attend to the visual stimuli (responding to some of
them: Go stimuli) was used. The P3a component was identified in
the novel minus standard (N-S) difference waveforms. Reaction
times (RTs) and hits to Go visual stimuli were also evaluated
with the aim of studying whether both aMCI subtypes modulate
the effects of involuntary capture of attention provoked by novel
stimuli on both measures.
MATERIALS AND METHODS
Sample
Fifty adults participated voluntarily in the present study and were
selected from a larger sample referred to our research group from
Primary Care Health Centres in Santiago de Compostela, Galicia
(Spain). The participants were divided into three groups: (1)
Control, comprising 20 adults (mean age: 65.8 years) with normal
cognitive functioning; (2) sdaMCI, comprising 19 adults (mean
age: 67 years); and (3) mdaMCI, comprising 11 adults (mean
age: 71 years). The three groups were matched regarding age and
years of education. The demographic and neuropsychological
measures of the three groups, and the differences between groups
(as determined by the corresponding analysis) are shown in
Table 1.
The present study complied with the ethical standards
established in the 1964 Declaration of Helsinki (Lynöe et al.,
1991) and was approved by the Galician Clinical Research
Ethics Committee (Xunta de Galicia, Spain). All participants
gave their written informed consent to participate in the
study, after the procedures were fully explained to them.
Participants did not report any medical or psychiatric diseases,
history of clinical stroke, traumatic brain injury, motor-sensory
deficits or substance abuse/dependence (alcohol or drug). Adults
with scores higher than 10 in depression screening (Geriatric
Depression Scale, GDS; Yesavage et al., 1983) were excluded. All
participants were right-handed, as evaluated by the Edinburgh
inventory (Oldfield, 1971), and all had normal audition and
normal or corrected-to-normal vision.
All participants then underwent the following
neuropsychological tests: (1) the Spanish version of the
Mini-Mental State Examination (MMSE; Folstein et al., 1975;
Spanish version by Lobo et al., 1999); (2) the Spanish version
of the Californian Verbal Learning Test (CVLT; Delis et al.,
1987; Spanish version, TAVEC by Benedet and Alexandre, 1998),
which evaluates short-delay and long-delay free recall, as well
as short-delay and long-delay recall with semantic cues; and (3)
the Spanish version of the Cambridge Cognitive Examination
(CAMCOG-R), which assesses impairments in perception,
attention-calculation, praxis, language and executive functioning
(Huppert et al., 1996).
When all participants were correctly diagnosed and classified
as Control, sdaMCI or mdaMCI, they voluntarily attended
our laboratory for psychophysiological evaluation by the
ERP technique. Participants categorized as having sdaMCI or
mdaMCI met the criteria for MCI outlined by Albert et al. (2011)
and the criteria for aMCI proposed by Petersen (2004). All aMCI
adults were characterized by self-reported memory complaints
corroborated by an informant, performance of less than 1.5 SDs
below age norms for the CVLT, essentially preserved activities
of daily living, and no dementia. In addition, participants with
mdaMCI scored less than 1.5 SDs below age- and education-
related norms in the MMSE and at least two cognitive subscales
of the Spanish version of the CAMCOG-R.
All control adults scored higher than the cut-off on memory,
general cognitive functioning, and specific cognitive domain
tests. For a more detailed description of the global samples, the
criteria for inclusion/exclusion, the tests used, and the diagnosis
and classification criteria, see Juncos-Rabadán et al. (2013).
Task
Participants performed an auditory-visual distraction-attention
task, which was an adaptation of the task used by Escera et al.
(1998, 2001). Five hundred auditory-visual (A-V) pairs of stimuli
(divided in two blocks) were presented. In each A-V pair, the
duration of the auditory stimulus was 150 ms and the duration
of the visual stimulus was 200 ms (onset-to-onset interval:
300 ms). An onset-to-onset interval between pairs of stimuli
of 2-s duration was used. Participants were instructed to pay
attention to the visual stimuli and to ignore the auditory stimuli.
See diagram of the task procedure in Figure 1.
The unattended auditory stimuli, of intensity 75 dB SPL, were
presented binaurally, via headphones. Three types of auditory
stimuli were presented: a standard tone of 1000 Hz (presentation
probability of 70%), a deviant tone of 2000 Hz (presentation
probability of 15%), and novel stimuli (different each time,
e.g., glass crashing, phone ringing; presentation probability of
15%). Three types of attended visual stimuli were also presented:
numbers (2, 4, 6, and 8), with a presentation probability of 33%,
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TABLE 1 | Mean values and standard deviation (SD, in brackets) of the demographic and neuropsychological measures.
Control N = 20 sdaMCI N = 19 mdaMCI N = 11 p = ∗ Bonferroni’s†
Age 65.8 (7.0) 67.0 (10.0) 71.0 (6.4) 0.241
Years of education 9.6 (4.6) 9.5 (4.4) 10.8 (5.3) 0.715
Gender (Female/Male) 15/5 9/10 8/3
WAIS, vocabulary 52.7 (8.7) 47.6 (12.2) 43.8 (17.0) 0.149
MMSE 28.7 (0.9) 27.0 (1.7) 23.5 (1.7) 0.001 Control > sdaMCI > mdaMCI
CVLT (Short delay free recall) 10.3 (1.7) 4.3 (1.7) 3.1 (1.8) 0.001 Control > sdaMCI, mdaMCI
CVLT (Short-delay cued recall) 12.3 (1.7) 5.8 (2.2) 5.6 (2.1) 0.001 Control > sdaMCI, mdaMCI
CVLT (Long-delay free recall) 11.5 (1.9) 5.5 (2.7) 3.2 (2.7) 0.001 Control > sdaMCI > mdaMCI
CVLT (Long-delay cued recall) 12.5 (2.2) 6.3 (2.8) 5.2 (2.9) 0.001 Control > sdaMCI, mdaMCI
CAMCOG-R (Orientation) 9.8 (0.2) 9.4 (0.2) 8.5 (3) 0.001 Control, sdaMCI > mdaMCI
CAMCOG-R (Language) 26.3 (1.9) 25.5 (2.5) 23.2 (2.9) 0.004 Control, sdaMCI > mdaMCI
CAMCOG-R (Attention and Calculation) 7.4 (1.6) 7.3 (1.7) 5.2 (2.8) 0.008 Control, sdaMCI > mdaMCI
CAMCOG-R (Praxis) 11.3 (1.0) 10.4 (2.5) 9.2 (2.9) 0.036 Control > mdaMCI
CAMCOG-R (Perception) 6.9 (1.5) 6.3 (1.3) 6.6 (1.6) 0.521
CAMCOG-R (Executive function) 19.8 (4.4) 16.2 (3.1) 13.5 (4.5) 0.001 Control > mdaMCI
∗ANOVA (Group); †p < 0.05. WAIS: Wechsler Adult Intelligence Scale; MMSE: Mini-Mental State Examination; CVLT: California Verbal Learning Test, CAMCOG-R:
Cambridge Cognitive Examination.
letters (a, c, e, and u), with a presentation probability of 33%,
and triangles (pointing right, left, upward or downward), with
a presentation probability of 34%. Participants were instructed
to respond (Go condition) to the numbers and to the letters by
pressing two different buttons, each with a different hand (the
buttons were counterbalanced among participants) and to inhibit
their responses to triangles (NoGo condition).
Electroencephalographic Recording
Recording sessions were conducted in a Faraday chamber, under
attenuated levels of light and noise. The participants were seated
on a comfortable chair during the electroencephalographic (EEG)
recording and they were instructed to move as little as possible
during the session.
Visual stimuli were presented with a subtended visual angle
of 1.7 × 3.3◦ of arc, on a 19′′ flat screen monitor (located at
a distance of one meter from the participant), with a vertical
refresh rate of 120 Hz. Forty-nine ring electrodes (placed in an
Easycap GmbH, according to the International 10–10 system)
were used for the EEG recording. An electrode placed at the
tip of the nose served as the reference for all active electrodes,
and an electrode at Fpz served as ground. Two electrodes
placed at the outer canthi of both eyes were used to record the
horizontal electro-oculogram (HEOG), whereas two electrodes
placed near the right eye (one supra-orbitally and other infra-
orbitally) were used to record the vertical electro-oculogram
(VEOG). The EEG signal was passed through a 0.01–100 Hz
analog bandpass filter and sampled at 500 Hz. The impedances
were below 10 k.
Off-line, ocular artifacts were corrected (using the method
Gratton et al., 1983) and the EEG epochs of −150–1300 ms
synchronized with each auditory stimulus (standard, deviant, or
novel) were extracted (epochs in Figures 3, 4, 5A were shortened
from −150 to 800 ms). Finally, three conditions were evaluated:
Standard (standard auditory stimulus-Go visual stimulus),
Deviant (deviant auditory stimulus-Go visual stimulus), and
Novel (novel auditory stimulus-Go visual stimulus). At least 50
artifact-free epochs were obtained for each condition. Epochs
related to the auditory stimuli-NoGo visual stimuli were not
evaluated.
The ERP waveforms obtained for the three groups (Control,
sdaMCI, and mdaMCI) in each condition are shown in Figure 3,
and the ERP waveforms obtained for the three conditions
(Standard, Deviant, and Novel) in each group are shown in
Figure 4.
Prior to averaging, the signal was filtered using a 0.1–30 Hz
(24 dB/octave slope) digital bandpass filter. In addition, the
epochs were corrected to the mean voltage of the 150-ms pre-
stimulus recording period, and those with signals exceeding
±100 µV, as well as the first five epochs of each block, were
rejected.
Finally, N-S difference traces were obtained (see Figure 5A)
with the aim of identifying and measuring P3a.
Data Analysis
The percentage of correct responses (hits) and RTs (between
the onset of the Go visual stimulus and pressing the key) were
evaluated for each group (Figure 2).
Two phases were identified in the temporal range of
P3a, for the control, sdaMCI and mdaMCI participants (see
Figures 3, 4, 5A): (1) early P3a (e-P3a), in a latency range
between 280 and 400 ms post-stimulus and with a maximum
amplitude at fronto-central locations, and (2) late P3a (l-P3a), in
a latency range between 350 and 500 ms post-stimulus, and with
a maximum amplitude at parieto-central locations. A scatter plot
of individual dates for the amplitudes of e-P3a and l-P3a (at Cz
electrode site) is presented in Figure 5B.
Baseline-to-peak amplitudes (in microvolts) and peak
latencies (in milliseconds, from the auditory stimulus onset to
the maximum peak) of e-P3a and l-P3a were measured at Fz, Cz,
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FIGURE 1 | Schematic representation of the auditory-visual distraction-attention task.
FIGURE 2 | Mean values of reaction times (RT, in ms- left figure) and percentage of hits (right figure) in each condition (Novel and Standard) in all three groups
(Control, sdaMCI, and mdaMCI).
and Pz electrode sites. Voltage and current source density (CSD)
maps were obtained for topographic analysis (see Figure 7).
Statistical Analysis
In order to evaluate the effects of the aMCI subtypes
and the involuntary capture of attention provoked by novel
stimuli, on the RT and the percentage of hits, two-factor
ANOVAs with a between-subject factor Group (with three
levels: Control, sdaMCI, and mdaMCI) and a within-subject
factor Condition (with two levels: Standard, and Novel) were
applied.
Two-factor ANOVAs (Group × Electrode Position) were
applied, with the aim of evaluating the effects of sdaMCI and
mdaMCI on e-P3a and l-P3a amplitudes. The Group factor
included three levels (Control, sdaMCI, and mdaMCI) and the
within-subject factor Electrode Position factor included three
levels (Fz, Cz, and Pz).
One-factor ANOVAs (Group) were used to evaluate the effects
of the aMCI subtypes on the e-P3a and l-P3a latencies at Cz, and
this factor included three levels (Control, sdaMCI, and mdaMCI).
Pairwise comparison of means (with Bonferroni corrections)
was carried out when the ANOVAs indicated significant results.
In addition, partial eta squared (η2p) and Cohen’s d value were
calculated for each significant comparison, with the aim of
determining the sizes of the effects. The Cohen’s d analysis was
carried out with G∗Power v.3.1.9.2 for Windows (Faul et al.,
2009).
Receiver operating characteristics (ROC) curves were
constructed when the Group factor exerted a main effect on the
e-P3a and l-P3a parameters. As in our previous studies (Lindín
et al., 2013), the ROC curve was constructed by determining the
sensitivity and specificity for a range of values of the e-P3a and
l-P3a parameters, and the tests were considered ideal when the
area under the curve (AUC) was greater than 0.7. In addition, a
line diagram was constructed with the sensitivity (true positive
rate) plotted on the vertical axis and the false positive rate (1
minus specificity) on the horizontal axis.
Results were considered statistically significant at p≤ 0.05. All
statistical analyses were performed using the IBM SPSS Statistics
package v.19 for Windows.
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FIGURE 3 | Grand-average ERP waveforms at the Fz, Cz, and Pz electrode sites, in the Standard, Deviant, and Novel conditions, comparing the three groups
(Control, sdaMCI, and mdaMCI). A, auditory stimulus; V, visual stimulus. Digital bandpass filter: 0.1–20 Hz.
RESULTS
The mean values and the standard deviations for the amplitudes
and latencies of e-P3a and l-P3a components are shown
in Table 2. The parameters of the ROC curve analysis are
summarized in Table 3, and the ROC curves of the best markers
for each type of diagnosis are presented in Figure 6.
Performance
The ANOVA (Group × Condition) showed significant effects of
the Condition factor [F(1,46) = 79.5; p < 0.001; η2p = 0.64] and
the Group × Condition interaction [F(2,46) = 5.9; p = 0.005;
η2p = 0.20] on the RT; this parameter was significantly longer
(see Figure 2) in the Novel condition [mean (M) = 691 ms;
standard deviation (SD) = 99.5] than in the Standard condition
(M = 651 ms; SD = 82.7) in all three groups (post hoc comparison:
Control: p < 0.001, d = 6.99; mdaMCI: p = 0.005, d = 7.31;
sdaMCI: p < 0.001, d = 8.46).
The ANOVA (Group× Condition) showed a significant effect
of the Group factor on the percentage of hits [F(1,46) = 8.7;
p < 0.001; η2p = 0.27]; this parameter was significantly higher
(see Figure 2) in the Control (M = 95.6%; SD = 4.1) and sdaMCI
(M = 95.0%; SD = 5.4) groups than in the mdaMCI (M = 85.9%;
SD = 11.4) group (post hoc comparisons of mdaMCI vs. sdaMCI:
p = 0.002, d = 1.17; mdaMCI vs. Control: p = 0.001, d = 1.2;
Control vs. sdaMCI: p = 1.00, d = 0).
e-P3a and l-P3a
For the e-P3a amplitude (see Figure 5A and Table 2), the
ANOVA (Group× Electrode Position) revealed significant effects
of the Group [F(2,47) = 3.4; p = 0.043; η2p = 0.13] and Electrode
Position [F(2,94) = 33.8; p < 0.001; ε = 0.7; η2p = 0.42] factors,
and for the Group× Electrode Position interaction [F(4,94) = 2.9;
p = 0.026; η2p = 0.11]. The e-P3a amplitude was significantly
larger in mdaMCI than sdaMCI at Pz (post hoc comparisons of
mdaMCI vs. sdaMCI: p = 0.017, d = 0.98; mdaMCI vs. Control:
p = 0.637, d = 0.50; Control vs. sdaMCI: p = 0.172, d = 0.64),
and close to being significantly larger in mdaMCI than sdaMCI
at Cz (p = 0.068, d = 0.83). In all groups, the e-P3a amplitude
was also significantly larger at the Cz than at the Fz (p < 0.001)
and Pz (p < 0.001) electrode sites, and in sdaMCI group it
was significantly larger at the Fz than at the Pz electrode site
(p = 0.009).
The ROC curves for e-P3a amplitude showed sensitivity and
specificity values of 0.91 and 0.68, respectively (for more details
see Table 3) for discriminating between the mdaMCI and sdaMCI
groups at the Pz electrode site (positive group: mdaMCI, negative
group: sdaMCI).
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FIGURE 4 | Grand-average ERP waveforms at the Fz, Cz, and Pz electrode sites, in the three groups (Control, sdaMCI, and mdaMCI), comparing the three
conditions (Standard, Deviant, and Novel). A, auditory stimulus; V, visual stimulus. Digital bandpass filter: 0.1–20 Hz.
For the l-P3a amplitude (see Figure 5A and Table 2), the
ANOVA (Group× Electrode Position) showed significant effects
of the Group [F(2,47) = 6.3; p = 0.004; η2p = 0.21] and Electrode
Position [F(2,94) = 34.0; p < 0.001; ε = 0.8; η2p = 0.42] factors,
and for the Group× Electrode Position interaction [F(4,94) = 2.4;
p = 0.055; η2p = 0.09].
The l-P3a amplitude was significantly larger in mdaMCI than
in sdaMCI (p = 0.004) and Control (p = 0.017) groups at Fz (post
hoc comparison of mdaMCI vs. sdaMCI: p = 0.035, d = 0.92;
mdaMCI vs. Control: p = 0.032, d = 0.98; Control vs. sdaMCI:
p = 1.00, d = 0.00), Cz (post hoc comparison of mdaMCI vs.
sdaMCI: p = 0.006, d = 1.14; mdaMCI vs. Control: p = 0.014,
d = 1.08; Control vs. sdaMCI: p = 1.00, d = 0.14) and Pz (post
hoc comparison of mdaMCI vs. sdaMCI: p = 0.002, d = 1.28;
mdaMCI vs. Control: p = 0.042, d = 0.99; Control vs. sdaMCI:
p = 0.498, d = 0.47) electrode sites. Moreover, in all groups, the
l-P3a amplitude was also significantly larger at the Cz than at the
Fz (p < 0.001) and Pz (p < 0.001) electrode sites, and in Control
group it was close to being significantly larger at Pz than at Fz
(p = 0.060) electrode sites.
The ROC curves for l-P3a amplitude showed sensitivity and
specificity values of, respectively, 0.73 and 0.79 at Fz, respectively,
0.64 and 0.74 at Cz, and, respectively, 0.82 and 0.68 at Pz for
discriminating between mdaMCI and sdaMCI groups (positive
group: mdaMCI, negative group: sdaMCI).
On the other hand, the ROC curves for l-P3a amplitude
showed sensitivity and specificity values of, respectively, 0.73 and
0.75 at Fz, respectively, 0.73 and 0.60 at Cz, and, respectively, 0.64
and 0.70 at Pz for discriminating between mdaMCI and Control
groups (positive group: mdaMCI, negative group: Control).
One-factor ANOVAs for the e-P3a and l-P3a latencies did not
reveal a significant effect of the Group factor.
Voltage maps (see Figure 7) for e-P3a and l-P3a also showed
larger amplitudes in the mdaMCI than in the sdaMCI and
Control groups. CSD maps (see Figure 7) revealed different
sources for e-P3a and l-P3a in all three groups: a centro-
frontal source was observed for e-P3a, and frontal and parietal
sources (with the parietal source increased in the mdaMCI) were
observed for l-P3a. These results are consistent with previous
research findings in healthy adults (see Correa-Jaraba et al., 2016).
In addition, frontal (in control and sdaMCI participants) and
occipital (in sdaMCI and mdaMCI participants) sinks for e-P3a,
and temporal sinks (in control and mdaMCI participants) for
l-P3a, were observed.
DISCUSSION
In this ERP study, involuntary processing of irrelevant auditory
stimuli followed by attended Go visual stimuli, and also RTs
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FIGURE 5 | (A) Grand-average ERP waveforms at the Fz, Cz, and Pz electrode sites, in the Novel minus Standard (N-S) difference waveforms, for the three groups
(Control, sdaMCI, and mdaMCI). A, auditory stimulus; V, visual stimulus. Digital bandpass filter: 0.1–20 Hz. (B) Scatter plot of individual dates (in the three groups) for
amplitudes of e-P3a and l-P3a, at Cz electrode site, in the N-S difference waveforms.
FIGURE 6 | ROC curves for the amplitudes that yielded the highest sensitivity and specificity values for each type of ROC analysis.
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FIGURE 7 | Voltage and current source density (CSD) maps for e-P3a and l-P3a maximum peaks, for the three groups (Control, sdaMCI, and mdaMCI).
and hits in response to the Go visual stimuli, were evaluated in
healthy adults and adults with sdaMCI and mdaMCI. The RTs
were longer in the Novel than in the Standard condition in all
three groups, suggesting capture of attention by novel stimuli
on the performance; in addition, the percentage of hits was
lower in mdaMCI participants than in the sdaMCI and control
participants. The ERPs results showed significant differences
between groups for both P3a phases: the e-P3a amplitude was
significantly larger in mdaMCI participants than in sdaMCI
participants, and the l-P3a amplitude was significantly larger
in mdaMCI participants than in sdaMCI and healthy control
participants. However, the e-P3a and l-P3a latencies did not differ
between groups.
Performance
The mdaMCI participants performed worse than the Control and
sdaMCI participants, as reflected in the lower percentage of hits
TABLE 2 | Mean values and standard deviations (SD, in brackets) of amplitudes
(µV) and latencies (ms) for early-P3a (e-P3a, 280–400 ms) and late-P3a (l-P3a,
350-500 ms) measured in N-S difference waveforms, for the three groups of







Amplitude e-P3a Fz 9.5 (4.5) 9.4 (5.8) 13.3 (5.1)
Cz 12.6 (4.4) 11.2 (6.8) 16.2 (5.1)
Pz 10.0 (4.2) 6.6 (6.2) 12.6 (6.1)
Latency e-P3a Cz 379 (27.6) 391 (25.0) 386 (42.7)
Amplitude l-P3a Fz 9.2 (3.5) 9.2 (4.1) 13.1 (4.4)
Cz 12.0 (3.9) 11.4 (4.5) 16.9 (5.1)
Pz 10.8 (3.6) 8.8 (4.9) 15.0 (4.8)
Latency l-P3a Cz 457 (26.1) 466 (32.1) 461 (34.5)
sdaMCI: single-domain amnestic mild cognitive impairment; mdaMCI: multi-
domain amnestic mild cognitive impairment.
in the first group. To our knowledge, only two previous studies
have evaluated differences in performance between sdaMCI and
mdaMCI participants using an A-V task (Cid-Fernández et al.,
2017a,b). The authors observed longer RT and fewer hits in
mdaMCI participants than in control (Cid-Fernández et al.,
2017a,b) and sdaMCI (Cid-Fernández et al., 2017b) participants.
In the present study, our results are partly consistent with the
obtained by (Cid-Fernández et al., 2017a,b), as they revealed
a behavioral decline in the mdaMCI participants relative to
the sdaMCI and Control participants, as reflected in a lower
percentage of hits, although there were no differences in RT
between groups.
On the other hand, longer RTs in response to Go visual
stimuli were observed in the Novel relative to the Standard
TABLE 3 | Sensitivity (Se) and specificity (Sp) values and area under the curve
(AUC), for the amplitudes of early-P3a (e-P3a) and late-P3a (l-P3a).
AUC Se Sp
e-P3a sdaMCI vs. mdaMCI
Amplitude Fz 0.72 0.73 0.74
Amplitude Cz 0.75 0.73 0.74
Amplitude Pz 0.79 0.91 0.68
l-P3a sdaMCI vs. mdaMCI
Amplitude Fz 0.78 0.73 0.79
Amplitude Cz 0.78 0.64 0.74
Amplitude Pz 0.82 0.82 0.68
Control vs. mdaMCI
Amplitude Fz 0.76 0.73 0.75
Amplitude Cz 0.77 0.73 0.60
Amplitude Pz 0.74 0.64 0.70
The highest sensitivity and specificity scores for each type of ROC analysis (for
those amplitudes in which the Group factor exerted a main effect) are highlighted
in bold type. sdaMCI: single-domain amnestic mild cognitive impairment; mdaMCI:
multi-domain amnestic mild cognitive impairment.
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condition, suggesting a distraction effect triggered by novel
stimuli in all three groups under study. This finding is consistent
with those of previous studies using A-V task in healthy young
adults (Escera et al., 1998, 2001; Cid-Fernández et al., 2014,
2016; Correa-Jaraba et al., 2016) and middle-aged and old
adults (Cid-Fernández et al., 2014, 2016; Correa-Jaraba et al.,
2016).
e-P3a and l-P3a
In the three groups of participants, two successive phases of
P3a were distinguished: an early phase (e-P3a) and a late phase
(l-P3a). Both phases showed maximum amplitude at the Cz
electrode site and were significantly larger at Cz relative to Fz
and Pz electrode sites. In addition, a fronto-central distribution
was observed for e-P3a, while l-P3a showed a parieto-central
distribution, as observed in the voltage maps (Figure 7).
In a recent study with the same task as used in the
present study, two phases of P3a were also identified in three
different healthy age groups (Young, Middle-aged, and Old),
in response to the novel auditory stimuli: e-P3a with a fronto-
central distribution and l-P3a with a parieto-central distribution
(Correa-Jaraba et al., 2016). In the aforementioned study, it was
suggested that e-P3a may be a correlate of the orienting response
to unexpected infrequent novel stimuli and that l-P3a may be
a correlate of evaluation of these stimuli. This interpretation
was based on the scalp distribution shown by the two P3a
phases and on the findings of some previous studies (as cited in
Correa-Jaraba et al., 2016). Specifically, differences were found
for the frontal and parietal P3a (see Friedman et al., 2001),
as P3a showed higher habituation at frontal than at parietal
sites (Courchesne et al., 1975; Knight, 1984; Friedman and
Simpson, 1994). The frontal part of P3a was considered an
index of processes associated with orienting toward the stimulus
(Cycowicz and Friedman, 1997; Friedman et al., 1998), because
habituation is a distinctive characteristic of the orienting response
(Siddle, 1991; Öhman, 1992); on the other hand, the posterior
part of P3a was interpreted as probably reflecting categorization
processes (Courchesne et al., 1975; Knight et al., 1995), because
it showed similar features to the P3b component evoked in
response to target stimuli (Friedman et al., 2001).
In the present study, both the distribution (central and
parietal) and latency of l-P3a were similar to those of the P3b
component. We therefore suggest that these ERP components
may be identical, although further studies should be carried out
to explore this possibility.
On the other hand, the findings of the present study are only
partly consistent with those reported by Escera et al. (1998, 2001),
who using a similar task observed two P3a consecutive phases,
in response to novel auditory stimuli, in young participants: (1)
an early phase, peaking between the 220 and 320 ms and with
a central distribution, and (2) a late phase, with latencies about
300–400 ms and a right frontal scalp maximum. The authors
proposed that the late P3a phase may reflect orienting of attention
toward the irrelevant novel stimulus, because its amplitude
increased when these stimuli could act as warning signals for
consecutive relevant visual stimuli, relative to conditions where
they did not act in this way (in a passive oddball task). On the
other hand, the early P3a phase was interpreted as an index of a
violation (provoked by a novel stimulus) of the regularity of an
established environment model (as cited in Correa-Jaraba et al.,
2016). The authors suggested that the early P3a phase may not
reflect orientation toward the stimulation because “the amplitude
did not increase when it acted as a warning signal, unlike in
the pure passive oddball task” (as cited in Correa-Jaraba et al.,
2016).
Effects of aMCI on the e-P3a and l-P3a
Parameters
Our findings revealed significant differences between the three
groups of participants for the amplitude of e-P3a and l-P3a
phases; however, they did not show differences between groups
for the latencies.
The e-P3a amplitude was significantly larger in adults with
mdaMCI than in adults with sdaMCI, which may indicate
a greater involuntary capture of the attention toward the
irrelevant novel stimuli in the first. Moreover, the increase
in the e-P3a amplitude seems be a potential biomarker for
discriminating between mdaMCI from sdaMCI participants, with
good sensitivity and acceptable specificity (see Table 3).
The l-P3a amplitude was also significantly larger in the
mdaMCI groups than in sdaMCI and Control groups, which
may indicate that participants with mdaMCI allocate more
attentional resources for evaluating irrelevant novel stimuli.
The increase in the l-P3a amplitude also seems to be a
potential biomarker for mdaMCI, as it was able to discriminate
between the mdaMCI and Control groups, and mdaMCI and
sdaMCI groups, with moderate sensitivity and specificity (see
Table 3).
Further studies should be carried out with larger samples
of participants to confirm our results and also to evaluate the
clinical usefulness of changes in e-P3a and l-P3a amplitudes for
identifying aMCI subtypes.
The observed differences between the mdaMCI group and
the other two groups (healthy controls and sdaMCI), together
with the absence of significant differences between the sdaMCI
and Control groups, provide evidence for the need to distinguish
aMCI subtypes with the aim of evaluating the P3a component as
a neurocognitive marker for diagnosing aMCI. Thus, it is possible
that the similarity between the P3a amplitudes of sdaMCI
and Controls may mask the differences between mdaMCI and
Controls.
The need to distinguish the aMCI subtypes was also evidenced
in our previous ERP studies in which other (Cespón et al.,
2015) or similar (Cid-Fernández et al., 2017a,b) cognitive tasks
were used. These studies revealed behavioral and neurocognitive
decline in mdaMCI participants relative to the sdaMCI and
control participants. Specifically, a decrease in the allocation of
attentional resources to target stimuli was observed in mdaMCI
participants relative to healthy controls, with no difference
between controls and sdaMCI participants (Cespón et al., 2015),
as well as deficits in executive processes in mdaMCI relative to
sdaMCI and control adults (Cespón et al., 2015; Cid-Fernández
et al., 2017a,b). Studies using neuroimaging techniques or
histopathologic analysis also supported the need to differentiate
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the two aMCI subtypes, as adults with mdaMCI showed different
brain damage than those with sdaMCI, e.g., a more widespread
white matter degeneration (Li et al., 2013; Liu et al., 2017) and
higher β-amyloid (Aβ) deposition (for a review see Ong et al.,
2013).
Several follow-up studies showed that the risk of conversion
to AD is higher in mdaMCI than in sdaMCI (Tabert et al.,
2006; Caffarra et al., 2008). In the present study, the larger
e-P3a and l-P3a amplitudes shown by the mdaMCI group than
by the sdaMCI group may also be optimal markers of possible
progression to AD; however, this assumption would be better
addressed in a longitudinal study comparing aMCI subtypes.
Cecchi et al. (2015) obtained smaller P3a amplitude in adults
with mild AD than in healthy controls; however, other authors
found no difference in this parameter between both groups
(Yamaguchi et al., 2000). Given that patients with AD showed
changes in P3a parameters relative to controls, we expected
to find similar changes in aMCI, especially in the mdaMCI
group. In this respect, the results of the present study are
partly consistent with the findings for AD, because we observed
significant differences between the mdaMCI group and the
sdaMCI and/or Control groups, with significantly larger e-P3a
and l-P3a amplitudes in the mdaMCI group. In addition, we did
not observe any differences between the sdaMCI and Control
groups in e-P3a or l-P3a parameters. First, it should be noted
that reports of the effects of AD, and other types of dementia, on
P3a are scarce, and the findings are to some extent inconsistent.
Moreover, due to the lack of research on the P3a component
in people with aMCI, comparison of our findings with other
relative findings is difficult. The discrepancies between the results
of the present and previous studies with AD patients may stem
from variations in the methods used, e.g., related to different task
characteristics.
In summary, healthy, sdaMCI, and mdaMCI participants
performed an auditory-visual distraction-attention task while
EEG activity was recorded. A greater orienting response to
unattended novel auditory stimuli, and allocation of more
attentional resources for the subsequent evaluation of these
stimuli (as indicated by larger e-P3a and l-P3a amplitudes,
respectively) were observed in the mdaMCI group relative to
the sdaMCI and Control groups. In addition, the sensitivity
and specificity scores provide evidence supporting the use of
larger e-P3a and l-P3a amplitudes as neurocognitive markers
of mdaMCI in the clinical setting. Follow-up studies should
investigate the predictive utility of e-P3a and l-P3a amplitudes to
identify people with aMCI who will develop AD and those who
will remain stable.
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